Online Only Articles

Minimal residual disease following autologous stem cell transplant in myeloma: impact on outcome is independent of induction regimen

St James’s Institute of Oncology, Leeds, UK
St James’s Institute of Oncology, Leeds, UK
Clinical Trials Research Unit, University of Leeds, UK
Clinical Trials Research Unit, University of Leeds, UK
Institute of Cancer Research, London, UK;University of Arkansas for Medical Sciences, Little Rock, AR, USA
Clinical Trials Research Unit, University of Leeds, UK
St James’s Institute of Oncology, Leeds, UK
Clinical Trials Research Unit, University of Leeds, UK
University of Birmingham, UK
University of Newcastle, UK
Institute of Cancer Research, London, UK;University of Arkansas for Medical Sciences, Little Rock, AR, USA
St James’s Institute of Oncology, Leeds, UK
Vol. 101 No. 2 (2016): February, 2016 https://doi.org/10.3324/haematol.2015.128215